These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9539636)

  • 21. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland.
    Chancellor JV; Hunsche E; de Cruz E; Sarasin FP
    Pharmacoeconomics; 2001; 19 Suppl 1():59-75. PubMed ID: 11280106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J; Sibley JT; Haga M
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention and treatment of NSAIDs-induced gastrointestinal complications by prostaglandin derivatives].
    Suzuki Y; Saito E; Wakabayashi T; Suwa A
    Nihon Rinsho; 2007 Oct; 65(10):1843-9. PubMed ID: 17926534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
    Chan FK
    Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity.
    Griffin MR; Scheiman JM
    Am J Med; 2001 Jan; 110(1A):33S-37S. PubMed ID: 11165994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers.
    Scheiman J; Isenberg J
    Am J Med; 1998 Nov; 105(5A):32S-38S. PubMed ID: 9855174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of arthritis antiinflammatory care: where are we today?
    Simon LS
    J Rheumatol Suppl; 1999 Apr; 56():11-7. PubMed ID: 10225535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Hawkey CJ
    Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
    Graham DY; White RH; Moreland LW; Schubert TT; Katz R; Jaszewski R; Tindall E; Triadafilopoulos G; Stromatt SC; Teoh LS
    Ann Intern Med; 1993 Aug; 119(4):257-62. PubMed ID: 8328732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs.
    Rahme E; Joseph L; Kong SX; Watson DJ; Pellissier JM; LeLorier J
    Pharmacoeconomics; 2001; 19(5 Pt 2):577-88. PubMed ID: 11465302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
    Burke TA; Zabinski RA; Pettitt D; Maniadakis N; Maurath CJ; Goldstein JL
    Pharmacoeconomics; 2001; 19 Suppl 1():33-47. PubMed ID: 11280104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of prescription of nonsteroidal antiinflammatory drugs and gastroprotective agents.
    LeLorier J
    J Rheumatol Suppl; 1995 Feb; 43():26-7. PubMed ID: 7752128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I
    J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.